Bimekizumab Data in axSpA Look Good Through 1 Year U.S. approval status for IL-17A/F inhibitor still in limbo Oct 05, 2023
Everything (Maybe) You Wanted to Know About Sarilumab for PMR Published details may raise questions about FDA's approval Oct 04, 2023
Actemra Biosimilar Approved But Biogen product doesn't get all the original's indications Oct 03, 2023
Early Oophorectomy May Accelerate Onset of Chronic Health Problems Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more Sep 13, 2023
Could This Neuroleptic Ward Off RA? Retrospective data suggest a preventive effect for old-line antipsychotic drug Sep 13, 2023
Here's Another Racial-Ethnic Disparity in Back Pain Care Nonwhite patients who overuse opioids are given nonpharmacologic alternatives less often Sep 12, 2023
Rheum Patients on HCQ: Stick With It or Face Heart Consequences Population-based study links adherence with risk for cardiovascular events Sep 11, 2023
Run This Test Before Diagnosing Fibromyalgia Study suggests 10% of cases may have easily treatable cause Sep 06, 2023
Joint Replacement Outcomes a Bit Better With Patient Reports Post-Surgery Not a huge benefit, study finds, but could be a step toward more consistent follow-up care Sep 01, 2023
U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
Blood Test Could Ease Diagnosis of Kids' Inflammatory Conditions Just one biomarker distinguished Kawasaki disease from others with similar clinical features Aug 25, 2023
Still No Easy Way to Take RA Patients Off Anti-TNF Drugs Randomized trial tests a withdrawal strategy, with mixed results Aug 23, 2023
Tool Predicts PsA Progression From Psoriasis, No Fancy Biomarkers Needed New model estimates risk from routine clinical parameters Aug 09, 2023
Certain Medications Tied to Post-COVID Pulmonary Fibrosis Rituximab and chemotherapy singled out in U.S. dataset Aug 08, 2023
Steroid Tapering Called Safe in Older RA Patients Trial follow-up demonstrates feasibility, though not without some risk Aug 07, 2023
Rheumatology Journals Rife With Faulty Conflict-of-Interest Disclosures Most authors receiving industry payments relevant to their research failed to report them Aug 03, 2023
Rotavirus Hospitalization in Kids Linked to Autoimmune Disease Later On Higher risks for arthritis, connective tissue disorders, other diseases seen in Korean study Jul 26, 2023
Gut Biome Altered in Inflammatory Arthritis, but Causal Direction Unclear Authors of new study ready to exonerate intestinal flora as a cause of joint disease Jul 26, 2023
Arthritis and Long COVID: A Double Whammy Worse pain and less functional ability with lingering virus symptoms, patients say Jul 24, 2023
TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases "Paradoxical" finding puzzles researchers Jul 22, 2023
Those Studies Backing Vagus Nerve Stimulation for RA? Umm... Randomized trial gives hopes for novel treatment a cold shower Jul 20, 2023
Biologics Keep Early RA in Check for at Least 1 Year New data confirm earlier shorter-term findings Jul 10, 2023
Imaging for Back and Joint Pain: Overuse Is an International Problem Australian primary care docs love to order scans, just like their American counterparts Jul 07, 2023
Xeljanz Edges Humira Just a Bit for Real-World RA Patients, Study Suggests Australian researchers perform "target trial emulation" to compare popular drugs Jun 30, 2023
Gut Microbiome Instability Associated With Lupus Nephritis Flares One specific gut microbe may be a major factor Jun 27, 2023
Check SSc-ILD Patients on Ofev for Malnutrition, Study Suggests Trial data show rates higher, though still low, with drug versus placebo Jun 26, 2023
Do Rheumatologists See Past RA Patients' Race? Randomized study finds no disparities in biologics prescribing, but questions linger Jun 15, 2023
Phase II Study: Bispecific Oral Drug Tops Leading JAK Inhibitor for RA Novel agent adds additional action in hopes of improving efficacy Jun 06, 2023
Two-Drug Combo Wins for Refractory Gout Phase III results back potential competitor for pegloticase-methotrexate treatment Jun 03, 2023
Cardiovascular Risk Models Still Fall Short for Arthritis Patients Of three major prognostic tools, none hit the mark Jun 02, 2023
More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
More Success for CAR T-Cell Therapy in Rheumatic Disease Stunning improvement for two patients with rare form of autoimmune myositis Jun 01, 2023
JAK Inhibitor Shows Promise in Severe Type of Sclerosis Study finds genetic basis long sought in disabling pansclerotic morphea, leading to effective tx Jun 01, 2023
Trial Shows RA Can Be Stopped at Preclinical Stage Familiar biologic halts progression in high-risk patients with just a few painful joints Jun 01, 2023
Benefits Found for Hand OA Drug Treatments In separate studies, one old standby and one newer biologic appeared helpful May 31, 2023
Here, Exactly, Is How Age of Onset Affects Giant Cell Arteritis Disease characteristics, risk factors for complications differ between young and old May 17, 2023
Oral Agent Cuts Fibromyalgia Pain in Trial, but ... Publication comes after another study's failure to demonstrate benefit May 15, 2023
